Konferenzen  >  Medizin & Gesundheitswesen  >  Pharmakologie und Arzneimittelentwicklung  >  Vereinigte Staaten

FDAMap

Is your team preparing for a Phase I or First-in-Man (FIM) study? Join our intensive workshop on “GMP for Phase I & FIM Studies” and gain critical insights into how to meet the quality and manufacturing standards expected by the U.S. Food & Drug Administration (FDA!) from day one.

FDA, Clinical Trials, GMP, FDA Regulation, FDA Compliance

Legislation in der Medizin und Pharmakologie,    Translationale Medizin, Klinische Studien

ComplianceOnline

This 2-day seminar explores the unique challenges facing quality functions of pharmaceutical and biotechnology companies. Attendees will learn practical implementation solutions as well as best practice descriptions that will allow management to effectively assess, manage and mitigate risk of poorly designed studies. Participants will learn statistical methods related to ICH guidelines and will discover how regulatory agencies, such as the FDA expect organizations to meet these guidelines.

ICH Quality Guidelines seminar, Statistical Considerations seminar, ICH guidelines, pharmaceutical manufacture, biotech manufacture, statistical methods, ICH guidelines compliance, statistical methods tools, statistical methods templates, regression analysis, confidence intervals, tolerance intervals, appropriate sample size, risk probability, process characterization for design space, FDA regulatory requirements

Biotechnologie,    Pharmakogenomik, Personalisierte Medizin

CHI

Join a vibrant community of scientists, trailblazers, and industry leaders at PepTalk 2026, as we mark 25 years of accelerating breakthroughs in biotherapeutic discovery and development. Renowned as one of the most influential events in protein science, PepTalk is where fresh ideas ignite, collaborations flourish, and next-generation solutions take shape.

This year’s expanded agenda features symposia and conference tracks, covering protein expression, production platforms, lab automation for higher throughput, analytical characterization and preformulation strategies for novel modalities, antibody discovery and development, and new this year - expression and development of therapeutic peptides and miniproteins.

Tel.: [781.972.5400];     Email: chi@healthtech.com

American Society for Experimental Neurotherapeutics (ASENT)

ASENT's 2026 Annual Meeting is the premier neuroscience and neurotherapeutics conference where leaders from providers and prescribers, employers, investors, fast-growing startups, big pharma, policymakers, funders & innovation centers gather to improve the process of bringing neurotherapeutics to market.

Tel.: [8332731556];     Email: jessica@asent.org

Neurology, Neurotherapeutics, Neuroscience, Biotech, Bioengineering, FDA, NIH, Drug Development, Pipeline Presentations